Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Juli 2017 12:00 ET | Quelle: MediWound Ltd.

MediWound to Host Second Quarter 2017 Financial Results Conference Call on August 3, 2017 at 8:30 a.m. Eastern Time

YAVNE, Israel, July 28, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
19. Juli 2017 16:15 ET | Quelle: MediWound Ltd.

BARDA Upsizes Contract with MediWound and Exercises Option to Fund Further NexoBrid® Indications

YAVNE, Israel, July 19, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
23. Juni 2017 08:26 ET | Quelle: MediWound Ltd.

BARDA Gives Notice of Intent to Exercise First Contract Option to Further Fund MediWound’s NexoBrid® Development

YAVNE, Israel, June 23, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
16. Juni 2017 08:00 ET | Quelle: MediWound Ltd.

Independent Study in Germany Shows NexoBrid® Reduces Average Burn Treatment Costs by nearly 30% Versus Standard of Care

YAVNE, Israel, June 16, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
05. Juni 2017 07:00 ET | Quelle: MediWound Ltd.

MediWound to Present at the Jefferies Global Healthcare Conference

YAVNE, Israel, June 05, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
02. Juni 2017 09:16 ET | Quelle: MediWound Ltd.

Poster Presentation Highlighting NexoBrid® Awarded “Best Poster” at the 52nd Congress of the Spanish Society of Aesthetic, Plastic and Reconstructive Surgery

YAVNE, Israel, June 02, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
18. Mai 2017 08:00 ET | Quelle: MediWound Ltd.

MediWound Announces Changes to its Board of Directors

YAVNE, Israel, May 18, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
08. Mai 2017 07:00 ET | Quelle: MediWound Ltd.

MediWound Reports First Quarter 2017 Financial Results

YAVNE, Israel, May 08, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
03. Mai 2017 07:00 ET | Quelle: MediWound Ltd.

MediWound Announces Successful GMP Manufacturing Audit by the Israeli Ministry of Health

YAVNE, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
01. Mai 2017 07:00 ET | Quelle: MediWound Ltd.

MediWound to Host First Quarter 2017 Financial Results Conference Call on May 8, 2017 at 8:30 a.m. Eastern Time

YAVNE, Israel, May 01, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...

Vorherige Seite